Weitere Daten zu Selexipag (Uptravi) und Macitentan (Opsumit) anlässlich des Jahreskongresses der European Respiratory Society (ERS) vorgestellt - Seite 3

Medienmitteilung PDF

---

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Actelion Pharmaceuticals Ltd via Globenewswire

HUG#1953701

--- Ende der Mitteilung ---

Actelion Pharmaceuticals Ltd
Gewerbestrasse 16 Allschwil Schweiz

ISIN: CH0010532478;